Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC

Clinical trial NCT07242274 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07242274
Sponsor: Jemincare
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)

Start date: 2025-12-31
Primary completion: 2027-12-31
Enrollment: 472

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.